PATPDF首页
>>
AU澳大利亚
Azaindole compounds as kinase inhibitors
Therapeutic agents comprising an anti-angiogenic agent in combination with an Src-inhibitor and thei
Androgen receptor modulators and methods of use thereof
Spacer moiety for poly(ethylene glycol) -modified peptides
Immunosuppressant compounds and compositions
Collagen matrix for soft tissue augmentation
Use of fused heterocyclic compounds as SCCE inhibitors for the treatment of skin conditions or cance
Fusion proteins for the treatment of CNS
Compositions for treating infection in cattle and swine
Antiviral acylguanidine compounds and methods
Methods for treating fibrous structures
Screening methods
Deployable multifunctional hemostatic agent
Specific glucocorticosteroid compound having anti- inflammatory activity
Polarizing photochromic devices and methods of making the same
Antifungal and antibacterial coating compositions
2-(amino or substituted amino)-5-(substituted oxymethyl)-phenol compounds, dyeing compositions conta
Pharmaceutical compositions for topical application
5-membered heterocycle-based p38 kinase inhibitors
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
Monatin tabletop sweetener compositions and methods of making same
Orally administered small peptides synergize statin activity
RNA interference mediated inhibition of gene expression using chemically modified short interfering
Penetrating pharmaceutical foam
Decontamination of prion-contaminated surfaces with phenols
N,N-dihalogenated amino acids and derivatives
Substituted 2,3-dihydro-1H-isoindol-1-one derivatives and methods of use
Ebola peptides and immunogenic compositions containing same
Flame retardants with high halogen content and low viscosity
Recombinant production of antimicrobial agents
Methods for identifying modulators of protein kinase c-epsilon (PKCe) and method of treatment of abe
Synthetic antimicrobial polypeptides
Albumin-binding derivatives of therapeutic peptides
Conjugates for photodynamic therapy
Controlled release formulations of opioid and nonopioid analgesics
Drug containing (2R)-2-propyloctanoic acid as the active ingredient
Phenyl pyrrolidine ether tachykinin receptor antagonists
Piscirickettsia salmonis antigens and use thereof
Process for producing antithrombin III composition
Substituted isoquinolinones
Dental compositions and methods with arylsulfinate salts
Bridged ring structures as pharmaceutical agents
Compositions useful as inhibitors of protein kinases
In vivo gene therapy of Parkinson's Disease
Heterocycle-substituted pteridine derivatives and their use in therapy
Development of new selective estrogen receptor modulators
Substrates and devices for applying a lip care formulation
Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (PPAR) dual ago
1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
HBV variants detection and application
Use of antagonist anti-CD40 antibodies for treatment of chronic lymphocytic leukemia
Binding assay components
Use of a pyrazole derivative for preparing medicaments for the prevention and the treatment of dysli
Pyridine compounds
Non-tabletted, chewable, individually dosed administration forms
System and method for transdermal delivery
Methods and reagents for the treatment of inflammatory disorders
Enhanced drug delivery
Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
Diamine and iminodiacetic acid hydroxamic acid derivatives
7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(ADP-ribose) polymerase inhibit
Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo eff
Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
Pyrazolopyrimidines
Novel GLP-1 analogues linked to albumin-like agents
P EF-TU expression units
Glycosylated steroid derivatives with anti-migratory activity
Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent
Substituted arylpyrazoles as parasiticidal agents
Mitotic kinesin inhibitors
Plant growth regulation
Polymer blends with improved notched impact strength
Compositions and methods to treat recurrent medical conditions
Compositions for treating or preventing obesity and insulin resistance disorders
Novel drug compositions and dosage forms of topiramate
Methods of enhancing immune response in the intradermal compartment and compounds useful in the meth
Dipeptidyl peptidase inhibitors
Self-processing plants and plant parts
Polymer-based sustained release device
Confectionery product
Valdecoxib compositions
Treatment of autoimmune diseases with antagonists which bind to B cell surface markers
Cosmetic and pharmaceutical foam with solid matter
Biodegradable vascular device with buffering agent
Composition for colouring of keratin fibres
Therapeutic uses of BPI protein products in humans with otitis media with effusion
Immediate release dosage form comprising shell having openings therein
Compositions containing anti-acne agents and the use thereof
Methods and products for manipulating uncoupling protein expression
Nucleic acids that enhance the synthesis of 2-acetyl-1-pyrroline in plants and fungi
Phenyl-[4-(3-phenyl-1H-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as IGF-IR inhibitors
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
Thiazole derivatives as A2b antagonists
Methods and systems for annotating biomolecular sequences
Method of preparing propionic acid-terminated polymers
Compositions and methods for modulating DHR96
Topical co-enzyme Q10 formulations and methods of use
Metal oxide particles useful as free radical scavnegers in sunscreen and cosmetic compositions
Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation
6,11-3C-bicyclic 8a-azalide derivatives
6912
首页
上一页
1
2
3
4
5
下一页
尾页